在挪威精英运动员中喘的患病率
Helene Støle Melsom1,2, Anders Randa3, Jonny Hisdal1,2
1Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Translational sports medicine
|April 24, 2024
概括
喘在精英运动员中普遍存在,特别是冬季和耐力运动员. 喘运动员表现出肺功能减弱和支气管过敏反应 (BHR) 的增加.
科学领域:
- 运动医学 运动医学
- 呼吸系统医学 呼吸系统医学
- 运动生理学 运动生理学
背景情况:
- 喘是精英运动员的重大健康问题,影响了他们的表现.
- 了解不同运动群体中的喘患病率和特征对于有针对性的干预至关重要.
研究的目的:
- 为了确定挪威夏季和冬季精英运动员的喘患病率.
- 调查喘和非喘运动员之间支气管过敏反应 (BHR),肺功能,呼出的氧化 (FeNO) 和过敏状态的差异.
主要方法:
- 包括2008年夏季奥运会 (n=80) 和2010年冬季奥运会 (n=55) 的挪威精英运动员.
- 进行了临床呼吸检查,肺功能测试,BHR评估的甲胆支气管挑战,FeNO测量和皮肤刺伤测试.
- 根据症状,临床检查和客观测量,诊断出喘.
主要成果:
- 冬季运动员 (50%) 的喘患病率高于夏季运动员 (20%).
- 在喘运动员中,52%是耐力运动员,6%是团队运动员,33%是技术运动员.
- 与非喘运动员相比,喘运动员的肺功能显著降低 (p < 0.001),严重BHR的患病率更高 (p < 0.001).
结论:
- 喘在挪威精英运动员中很常见,冬季和耐力运动员受到影响最多.
- 喘运动员的特点是肺功能减弱和更严重的BHR.
- 需要对高患病率运动群体的喘预防和管理给予更多的关注.
更多相关视频
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
390
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
390
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
279
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
279


